Search Results for: organoids

‘We don’t want to freak people out’: about that Jacob Hanna human embryo model startup

/ / 5 Comments
Jacob Hanna Renewal Bio

Stem cell biologist Jacob Hanna has a new startup called Renewal Bio. Its goal is to harvest cells or tissues from human embryo or fetus models for clinical use. I believe that their commercial ambitions have so far outstripped careful thought and discussion in the broader community of researchers. There are major risks here for […]

‘We don’t want to freak people out’: about that Jacob Hanna human embryo model startup Read More »

Weekly science reads: Macchiarini trial, somites, CRISPR babies

/ / Leave a Comment
organoids with somites, cool science

This has been one of those weeks where I spent some time thinking about taking risks in science. How much risk one should take? Risks can come in many forms. It could be at the core level at the bench doing specific experiments and not others. There’s risk in clinical trials, and even in advocacy. Sometimes

Weekly science reads: Macchiarini trial, somites, CRISPR babies Read More »

Weekly reads: fibroblasts, cancer stem cells, Parkinson’s

/ / Leave a Comment
fibroblasts stained

It seems like the field of cell biology has mixed feelings about fibroblasts so I’m going to start off there with the recommended reads. But first, check out our stem cell YouTube channel as we are steadily heading toward 500 subscribers and 30,000 views. Please subscribe. I’ve pasted one of our top videos below, which

Weekly reads: fibroblasts, cancer stem cells, Parkinson’s Read More »

Stem cell therapy for heart disease: what you need to know

/ / 1 Comment
stem cell therapy for hearts

How much promise is there today for stem cell therapy for heart disease? Where do things stand with the clinical research? Patients regularly ask me these kinds of questions. The goal of today’s post is to update you on where things stand. What’s in this post Stem Cell Therapy | Clinical Trials | Delivery of

Stem cell therapy for heart disease: what you need to know Read More »

Weekly reads: CAR-T cell good news, Califf fight, stem cells on lymph

/ / 1 Comment
CAR-T-cell-infographic

Not everything in biomedical science is a ground-breaking discovery or clinical game-changer, but CAR-T cell technology is a combination of both. CAR-T cell good news We have such good news in this new pub on long-term benefits: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells, Nature. Another recent CAR-T cell article, this one in Science,

Weekly reads: CAR-T cell good news, Califf fight, stem cells on lymph Read More »

Recommended reads: senolytics, cow iPS cells, big CIRM royalty

/ / 1 Comment
Senolytics Steve Horvath

When we hear the word senile we might think stereotypically of an older person who has cognitive impairment, but some argue that senility can apply to cells too as they age and that such cells can be targeted by drugs called senolytics. Unfortunately, the supplements industry has picked up on this idea to sell iffy

Recommended reads: senolytics, cow iPS cells, big CIRM royalty Read More »

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis

/ / Leave a Comment
CRISPR-Model-Jacob-Corn-e1464305007640

The big news of the week was the launch of Altos labs and their ambitious plan to tackle aging through cell therapies. Altos has recruited a large number of top cell biologists away from academia. That team plus top biotech execs and a $3B war chest make Altos one to watch in coming years. I

Weekly reads: aging, CRISPR delivery, hair, oocytes, paralysis Read More »